Maria Agallou

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins

Maria Agallou, Evita Athanasiou, Olga S. Koutsoni et al. · Frontiers in Immunology · 2014 · 103 citations · Full text

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis

Evita Athanasiou, Maria Agallou, Spyros Tastsoglou et al. · Frontiers in Immunology · 2017 · 82 citations · Full text

Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis

Maria Agallou, Maritsa Margaroni, Evdokia Karagouni · Vaccine · 2011 · 69 citations

Vaccination, Mucosal Vaccination, Cellular Vaccination +11

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble <em>Leishmania</em> antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis

Maritsa Margaroni, Maria Agallou, Evita Athanasiou et al. · International Journal of Nanomedicine · 2017 · 53 citations · Full text

Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine

Maria Agallou, Maritsa Margaroni, Evita Athanasiou et al. · PLoS neglected tropical diseases · 2017 · 49 citations · Full text